Provided by Tiger Fintech (Singapore) Pte. Ltd.

BriaCell Therapeutics Corp.

4.47
+0.01000.22%
Post-market: 4.470.00000.00%16:00 EDT
Volume:18.53K
Turnover:81.62K
Market Cap:16.58M
PE:-0.34
High:4.57
Open:4.41
Low:4.18
Close:4.46
Loading ...

BriaCell announces resolution of lung metastasis in patient receiving Bria-OTS

TIPRANKS
·
03 Feb

BriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS™

GlobeNewswire
·
03 Feb

BriaCell Completes 15:1 Share Consolidation for Nasdaq Compliance

TIPRANKS
·
28 Jan

BriaCell Announces Completion of 15:1 Share Consolidation

GlobeNewswire
·
28 Jan

BriaCell Plans Share Consolidation for Nasdaq Compliance

TIPRANKS
·
04 Jan

BriaCell Announces Rescheduling of its Annual General Meeting of Shareholders to February 5, 2025

GlobeNewswire
·
04 Jan

BriaCell Announces Proposed Effective Date of Share Consolidation

GlobeNewswire
·
04 Jan

Insider Purchases Worth US$5.52m See Losses As BriaCell Therapeutics Market Value Drops To CA$40m

Simply Wall St.
·
19 Dec 2024

BriaCell Adapts Meeting Procedures Amid Postal Strike

TIPRANKS
·
18 Dec 2024

Briacell Therapeutics Corp reports results for the quarter ended October 31 - Earnings Summary

Reuters
·
17 Dec 2024

BriaCell Therapeutics Reports Quarterly Financial Loss

TIPRANKS
·
17 Dec 2024

BriaCell Therapeutics Closes $5.5 Million Offering

TIPRANKS
·
14 Dec 2024

BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer

GlobeNewswire
·
13 Dec 2024

BRIEF-Briacell Therapeutics Prices Public Offering Of 7.4 Mln Shares And Warrants At $0.75 Each

Reuters
·
12 Dec 2024

BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering

GlobeNewswire
·
12 Dec 2024

BriaCell Therapeutics Plans Public Offering

TIPRANKS
·
12 Dec 2024